🍽️ fucoidan

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations    |     πŸ“ Dosage Seen

Data Contradictions β€” Limits of Certainity

Impacted of fucoidan On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Increases

Bacteria Impacted by fucoidan

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Peptostreptococcaceae family Decreases 👪 Source Study
Clostridiaceae family Increases 👪 Source Study
Lachnospiraceae family Increases 👪 Source Study
Rikenellaceae family Increases 👪 Source Study
Paraprevotella genus Decreases 📓 Source Study
Romboutsia genus Decreases 📓 Source Study
Butyrivibrio genus Decreases 👪 Source Study
Prevotella genus Decreases 👪 Source Study
Akkermansia genus Increases 👪 Source Study
Anaerovibrio genus Increases 👪 Source Study
Butyricicoccus genus Increases 📓 Source Study
Coprococcus genus Increases 📓 Source Study
Prevotella genus Increases 📓 Source Study
Rikenella genus Increases 📓 Source Study
unclassified Paraprevotella no rank Decreases 👶 Source Study
unclassified Romboutsia no rank Decreases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Butyricicoccus no rank Increases 👶 Source Study
unclassified Coprococcus no rank Increases 👶 Source Study
unclassified Prevotella no rank Increases 👶 Source Study
Neisseriales order Decreases ⚗️ Source Study
Flavobacteriales order Increases ⚗️ Source Study
Butyrivibrio fibrisolvens species Decreases 📓 Source Study
Butyrivibrio proteoclasticus species Decreases 📓 Source Study
Prevotella ruminicola species Decreases 📓 Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
[Clostridium] dakarense species Decreases 👶 Source Study
Paraprevotella clara species Decreases 👶 Source Study
Paraprevotella xylaniphila species Decreases 👶 Source Study
Romboutsia hominis species Decreases 👶 Source Study
Romboutsia ilealis species Decreases 👶 Source Study
Romboutsia lituseburensis species Decreases 👶 Source Study
Romboutsia sedimentorum species Decreases 👶 Source Study
Romboutsia timonensis species Decreases 👶 Source Study
Butyricicoccus faecihominis species Increases 👶 Source Study
Butyricicoccus intestinisimiae species Increases 👶 Source Study
Butyricicoccus porcorum species Increases 👶 Source Study
Butyricicoccus pullicaecorum species Increases 👶 Source Study
Coprococcus catus species Increases 👶 Source Study
Coprococcus comes species Increases 👶 Source Study
Coprococcus eutactus species Increases 👶 Source Study
Coprococcus phoceensis species Increases 👶 Source Study
Prevotella amnii species Increases 👶 Source Study
Prevotella aurantiaca species Increases 👶 Source Study
Prevotella bivia species Increases 👶 Source Study Infectious bacteria
Prevotella brevis species Increases 👶 Source Study
Prevotella conceptionensis species Increases 👶 Source Study
Prevotella corporis species Increases 👶 Source Study
Prevotella dentalis species Increases 👶 Source Study
Prevotella dentasini species Increases 👶 Source Study
Prevotella denticola species Increases 👶 Source Study
Prevotella disiens species Increases 👶 Source Study
Prevotella falsenii species Increases 👶 Source Study
Prevotella fusca species Increases 👶 Source Study
Prevotella herbatica species Increases 👶 Source Study
Prevotella histicola species Increases 👶 Source Study
Prevotella intermedia species Increases 👶 Source Study Infectious bacteria
Prevotella jejuni species Increases 👶 Source Study
Prevotella marseillensis species Increases 👶 Source Study
Prevotella melaninogenica species Increases 👶 Source Study Pathogen
Prevotella merdae species Increases 👶 Source Study
Prevotella micans species Increases 👶 Source Study
Prevotella multiformis species Increases 👶 Source Study
Prevotella nigrescens species Increases 👶 Source Study
Prevotella oryzae species Increases 👶 Source Study
Prevotella pallens species Increases 👶 Source Study
Prevotella pectinovora species Increases 👶 Source Study
Prevotella phocaeensis species Increases 👶 Source Study
Prevotella rara species Increases 👶 Source Study
Prevotella ruminicola species Increases 👶 Source Study
Prevotella scopos species Increases 👶 Source Study
Prevotella sp. P5-119 species Increases 👶 Source Study
Prevotella veroralis species Increases 👶 Source Study
Rikenella microfusus species Increases 👶 Source Study
Akkermansia muciniphila species Increases 📓 Source Study
Anaerovibrio lipolyticus species Increases 📓 Source Study
Butyrivibrio fibrisolvens 16/4 strain Decreases 👶 Source Study
Butyrivibrio proteoclasticus B316 strain Decreases 👶 Source Study
Prevotella ruminicola 23 strain Decreases 👶 Source Study
Akkermansia muciniphila ATCC BAA-835 strain Increases 👶 Source Study
Chlamydiae/Verrucomicrobia group superphylum Increases ⚗️ Source Study

Impact of fucoidan on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.2 -0.2
Acne 0.9 0.9
ADHD 1.1 0.5 1.2
Age-Related Macular Degeneration and Glaucoma 0.3 0.3
Allergic Rhinitis (Hay Fever) 0.2 0.2 0
Allergies 1.1 0.8 0.38
Allergy to milk products 0.5 -0.5
Alopecia (Hair Loss) 0.3 -0.3
Alzheimer's disease 2.3 1.2 0.92
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.9 2.3 -1.56
Ankylosing spondylitis 0.5 1 -1
Anorexia Nervosa 0.3 0.3
Asthma 0.9 0.6 0.5
Atherosclerosis 0.9 0.2 3.5
Atrial fibrillation 0.8 1.4 -0.75
Autism 2.9 2.8 0.04
Bipolar Disorder 1.1 0.8 0.38
Brain Trauma 0.2 0.2
Breast Cancer 0.2 0.5 -1.5
Carcinoma 0.8 0.9 -0.13
Celiac Disease 0.5 0.3 0.67
Cerebral Palsy 0.2 0.5 -1.5
Chronic Fatigue Syndrome 1.5 0.3 4
Chronic Kidney Disease 1.5 0.7 1.14
Chronic Obstructive Pulmonary Disease (COPD) 1.1 0.5 1.2
Chronic Urticaria (Hives) 0.8 0.8
Coagulation / Micro clot triggering bacteria 0.5 0.3 0.67
Colorectal Cancer 0.6 0.8 -0.33
Constipation 0.2 0.3 -0.5
Coronary artery disease 0.9 0.5 0.8
COVID-19 3.3 2.3 0.43
Crohn's Disease 2.7 2.3 0.17
deep vein thrombosis 0.3 -0.3
Depression 3.6 1.1 2.27
Eczema 0.8 0.3 1.67
Endometriosis 1.5 -1.5
Epilepsy 1.4 1.1 0.27
erectile dysfunction 0.3 -0.3
Fibromyalgia 0.5 0.5
Functional constipation / chronic idiopathic constipation 0.8 0.5 0.6
gallstone disease (gsd) 0.5 0.5
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.2 0.2 0
Generalized anxiety disorder 0.6 0.6
giant cell arteritis 0.3 -0.3
Glioblastoma 0.7 0.7
Gout 0.9 0.9
Graves' disease 0.6 0.4 0.5
Halitosis 0.2 -0.2
Hashimoto's thyroiditis 0.7 0.6 0.17
Hidradenitis Suppurativa 0.2 -0.2
hypercholesterolemia (High Cholesterol) 0.6 0.2 2
hyperglycemia 0.9 0.3 2
Hyperlipidemia (High Blood Fats) 0.3 -0.3
hypertension (High Blood Pressure 2.5 1.2 1.08
Hypothyroidism 1.5 0.4 2.75
Hypoxia 0.2 0.3 -0.5
IgA nephropathy (IgAN) 0.4 0.3 0.33
Inflammatory Bowel Disease 1.7 0.2 7.5
Insomnia 0.2 0.2 0
Intelligence 0.2 0.9 -3.5
Irritable Bowel Syndrome 1.1 1.4 -0.27
Liver Cirrhosis 2.4 1.4 0.71
Long COVID 3.2 2.6 0.23
Low bone mineral density 0.9 0.9
Lung Cancer 0.9 0.9
ME/CFS with IBS 0.4 0.4
ME/CFS without IBS 0.2 0.3 -0.5
Metabolic Syndrome 3.6 3.2 0.13
Mood Disorders 4.6 3.4 0.35
multiple chemical sensitivity [MCS] 0.3 -0.3
Multiple Sclerosis 1.1 1.1 0
Multiple system atrophy (MSA) 0.9 -0.9
myasthenia gravis 0.3 0.3
Neuropathy (all types) 0.6 -0.6
neuropsychiatric disorders (PANDAS, PANS) 0.3 0.3 0
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2.2 0.4 4.5
Obesity 3.5 2.4 0.46
obsessive-compulsive disorder 1.7 0.7 1.43
Osteoarthritis 0.3 -0.3
Osteoporosis 0.9 0.9
Parkinson's Disease 1.7 2.7 -0.59
Polycystic ovary syndrome 1.1 0.8 0.38
Postural orthostatic tachycardia syndrome 0.6 0.6
Premenstrual dysphoric disorder 0.6 0.6
primary biliary cholangitis 0.3 -0.3
Psoriasis 1.4 1.5 -0.07
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 2.1 3 -0.43
Schizophrenia 1.8 2.2 -0.22
scoliosis 0.2 0.9 -3.5
sensorineural hearing loss 0.3 0.3 0
Sjögren syndrome 0.5 0.2 1.5
Sleep Apnea 1.1 0.6 0.83
Small Intestinal Bacterial Overgrowth (SIBO) 0.2 -0.2
Stress / posttraumatic stress disorder 1.5 0.3 4
Systemic Lupus Erythematosus 0.8 1.6 -1
Tic Disorder 0.2 0.2 0
Tourette syndrome 0.3 -0.3
Type 1 Diabetes 0.2 1.6 -7
Type 2 Diabetes 2.8 2.7 0.04
Ulcerative colitis 2.6 0.4 5.5
Unhealthy Ageing 1.1 0.8 0.38

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)